What Solutions We Provide:
- Treatment Patterns
- Detailed business rules to identify lines of treatment, adaptable to different indications
- Distribution of mono and combination regimens in various lines
- Treatment sequencing – predecessor, successor regimens
- Identification of patients who have failed treatment with specific regimens of interest
- Outcomes
- Effectiveness outcomes (OS, TPFS, TTTD, TTNT, TTTDS)
- Safety outcomes (AE occurrence rate, acute care events, OP-35)
- Comparative effectiveness – within RWD, between RWD and clinical trial data
- Synthetic control arm from RWD
- Burden of Illness
- Epidemiological – incidence, prevalence
- Cost (to payer, to patient, by line, of regimen failure)
- HRU
- Comorbidities, concomitant medications
- Examples of RWD-Based Studies Conducted in the Recent Past
- Disease and treatment characteristics of men diagnosed with metastatic hormone-sensitive prostate cancer in real life: analysis from a commercial claims database
- Treatment patterns and outcomes analysis in diffuse large B-cell lymphoma
- A population-based study of the association of PSA doubling time (PSADT) with metastasis-free survival (MFS) and overall survival (OS) in non-metastatic CRPC patients
- Utilization of hypomethylating agents and associated outcomes in elderly acute myeloid leukemia (AML) patients
- Duration of treatment of multiple myeloma regimens in patients with relapsed or refractory multiple myeloma
- Treatment sequencing patterns observed in atopic dermatitis patients
- Evaluation of efficacy outcomes among follicular lymphoma treated patients in a real-world setting
- Treatment patterns and comorbidities analysis of patients with small cell lung cancer in a large EMR database
- Burden of illness and extent of hospitalization in RSV
- Patient journey across the diagnostic and treatment path in lupus and PsE